TabletsCyclophosphamideTablets, Enteric-CoatedAntineoplastic Combined Chemotherapy ProtocolsPhosphoramide MustardsVincristineDoxorubicinAntineoplastic Agents, AlkylatingChemistry, PharmaceuticalExcipientsPrednisoneDrug CompoundingImmunosuppressive AgentsDrug Administration ScheduleDelayed-Action PreparationsMethotrexatePulse Therapy, DrugEtoposideTechnology, PharmaceuticalEpirubicinTreatment OutcomeCombined Modality TherapyMethylcelluloseBusulfanThiotepaPrednisoloneAdministration, OralPowdersBreast NeoplasmsRemission InductionAntibodies, Monoclonal, Murine-DerivedFluorouracilLeukopeniaVidarabineBone Marrow TransplantationGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinDisease-Free SurvivalSolubilityDose-Response Relationship, DrugTransplantation, AutologousDrug Therapy, CombinationMethylprednisoloneHardnessCystitisAdministration, MetronomicWhole-Body IrradiationHematopoietic Stem Cell TransplantationChemotherapy, AdjuvantTime FactorsSurvival AnalysisCarmustineTransplantation ConditioningSurvival RateMelphalanImmunosuppressionAzathioprineWegener GranulomatosisCapsulesLupus NephritisLubricantsMesnaIfosfamideAntineoplastic AgentsDosage FormsCisplatinTherapeutic EquivalencyFollow-Up StudiesRecurrenceNeutropeniaChlorambucilAcroleinMitoxantroneDrug StabilityCellulosePovidoneBleomycinTransplantation, HomologousAlkylating AgentsHematopoietic Stem Cell MobilizationBiological AvailabilityLeukocyte CountProcarbazineHardness TestsAdministration, BuccalAnemia, AplasticDexamethasoneCytarabinePaclitaxelLymphoma, Large B-Cell, DiffuseSuspensionsAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisInfusions, IntravenousCarboplatinClinical Trials as TopicDrug EvaluationProspective StudiesNeoplasm StagingVomitingDrug Combinations